President Trump has rescinded an executive order from the Biden administration which had been aimed at exploring new healthcare payment models to lower prescription costs for Medicare and Medicaid beneficiaries. The order, seen as “unpopular, inflationary, illegal, and radical practices” by Trump, proposed methods to lower costs and incentivise manufacturers to expedite clinical trials.
Why Healthcare Organisations Have To Act Decisively In The Shadow Of New HIPAA Updates
The recent amendments to the Health Insurance Portability and Accountability Act (HIPAA) represent a significant overhaul in healthcare data privacy, addressing the need to protect
